318 related articles for article (PubMed ID: 12455279)
1. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
Kearney MC; Bingham J; Bergland R; Meade-D'Alisera P; Puchner PJ
J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Foley SJ; Soloman LZ; Wedderburn AW; Kashif KM; Summerton D; Basketter V; Holmes SA
J Urol; 2000 Feb; 163(2):496-8. PubMed ID: 10647664
[TBL] [Abstract][Full Text] [Related]
4. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
[TBL] [Abstract][Full Text] [Related]
5. The effects of finasteride on hematuria associated with benign prostatic hyperplasia: a preliminary report.
Puchner PJ; Miller MI
J Urol; 1995 Nov; 154(5):1779-82. PubMed ID: 7563345
[TBL] [Abstract][Full Text] [Related]
6. The treatment of gross hematuria secondary to prostatic bleeding with finasteride.
Sieber PR; Rommel FM; Huffnagle HW; Breslin JA; Agusta VE; Harpster LE
J Urol; 1998 Apr; 159(4):1232-3. PubMed ID: 9507842
[TBL] [Abstract][Full Text] [Related]
7. Re: A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride.
Harrison RH
J Urol; 2000 Nov; 164(5):1670-1. PubMed ID: 11203073
[No Abstract] [Full Text] [Related]
8. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
[TBL] [Abstract][Full Text] [Related]
9. [The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia].
Djavan B; McConnell J
Wien Med Wochenschr; 1996; 146(8):165-8. PubMed ID: 8767401
[TBL] [Abstract][Full Text] [Related]
10. [Finasteride: an effective therapeutic for benign prostatic hyperplasia related gross hematuria in patients receiving anticoagulant].
Lin YH; Jiang YG; Li MC; Peng T
Zhonghua Nan Ke Xue; 2009 Jan; 15(1):31-3. PubMed ID: 19288745
[TBL] [Abstract][Full Text] [Related]
11. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
Agha AH; Roy JB; Culkin DJ; Lyon K
Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
[TBL] [Abstract][Full Text] [Related]
12. [Effects of finasteride on hematuria associated with benign prostatic hyperplasia: a meta-analysis].
Jiang Y; Long YF
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):726-9. PubMed ID: 21090349
[TBL] [Abstract][Full Text] [Related]
13. Role of finasteride in the treatment of recurrent hematuria secondary to benign prostatic hyperplasia.
Carlin BI; Bodner DR; Spirnak JP; Resnick MI
Prostate; 1997 May; 31(3):180-2. PubMed ID: 9167770
[TBL] [Abstract][Full Text] [Related]
14. Effects of finasteride on vascular endothelial growth factor.
Häggström S; Tørring N; Møller K; Jensen E; Lund L; Nielsen JE; Bergh A; Damber JE
Scand J Urol Nephrol; 2002; 36(3):182-7. PubMed ID: 12201932
[TBL] [Abstract][Full Text] [Related]
15. Impact of finasteride treatment on perioperative bleeding before transurethral resection of the prostate: a prospective randomized study.
Lund L; Møller Ernst-Jensen K; Tørring N; Erik Nielsen J
Scand J Urol Nephrol; 2005; 39(2):160-2. PubMed ID: 16019771
[TBL] [Abstract][Full Text] [Related]
16. Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
Fenter TC; Davis EA; Shah MB; Lin PJ
Am J Manag Care; 2008 May; 14(5 Suppl 2):S154-9. PubMed ID: 18611089
[TBL] [Abstract][Full Text] [Related]
17. The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
Hill M; Petrik R; Hampl R; Stárka L
Horm Metab Res; 1996 Oct; 28(10):562-4. PubMed ID: 8934217
[TBL] [Abstract][Full Text] [Related]
18. Finasteride to evaluate the efficacy of dutasteride in the management of patients with lower urinary tract symptoms and enlarged prostate.
Ravish IR; Nerli RB; Amarkhed SS
Arch Androl; 2007; 53(1):17-20. PubMed ID: 17364459
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks.
Donohue JF; Hayne D; Karnik U; Thomas DR; Foster MC
BJU Int; 2005 Dec; 96(9):1319-22. PubMed ID: 16287453
[TBL] [Abstract][Full Text] [Related]
20. [The long-term treatment of patients with benign prostatic hyperplasia using Proscar].
Lopatkin NA; Roilans PJ; Stoner E
Urol Nefrol (Mosk); 1996; (1):2-4. PubMed ID: 8659035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]